Boyu Capital Consultancy Co., Ltd. is a private equity firm established in 2010, headquartered in Hong Kong, with an additional office in Beijing, China. The firm specializes in buyout investments primarily within the Chinese market, focusing on sectors such as media, technology, healthcare, consumer goods, retail, and financial services. Boyu Capital aims to leverage its expertise and local market knowledge to identify and invest in promising opportunities across these industries, contributing to their growth and development.
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Evat Master is a SaaS platform that specializes in providing an independent declaration of European VAT for cross-border e-commerce businesses. Its platform allows users to complete all necessary tax reporting procedures online, providing clients with a convenient platform to report their taxes.
Shuaike is a company specializing in pet supplies and food. The brand is derived from the English "seek", adheres to the brand management philosophy of "only natural fresh meat", and aims to make the best natural and healthy food for pets all over the world. American micropowder puffing technology and fresh meat emulsification technology, combined with local fresh chicken and duck meat, natural food, organic vegetables, fruits and other nutrients to extract natural fresh meat pet food, now export dog food and cat food Shuikesaijia Natural cat and dog food.
Hangzhou MoreSec Technology Co., Ltd. is a company based in Hangzhou, China, specializing in internet security software. It focuses on integrating threat intelligence and artificial intelligence technologies into enterprise security systems. MoreSec aims to provide comprehensive security solutions tailored for the cloud computing and Internet of Things (IoT) environments, addressing the evolving needs of businesses in safeguarding their digital assets.
ArriVent Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for cancer. The company aims to address unmet medical needs by leveraging its team's extensive experience in drug development. ArriVent is advancing its lead candidate, furmonertinib, along with a pipeline of novel therapeutics, including next-generation antibody-drug conjugates. The company's initial emphasis is on solid tumors, reflecting its commitment to improving outcomes for cancer patients through differentiated medicines.
Recurrent.ai is a Chinese company that provides AI-enabled corporate services to improve sales efficiency. Through a full set of self-study engine sales dialogue analysis system, it helps companies to transfer sales, customer service and customer dialogue from voice to text, providing full machine quality inspection and sales efficiency optimization. Core functions such as customer portrait records, fully automatic generation of big data dialogue analysis reports, help companies reduce time and labor costs, increase sales conversion rate, and effectively drive decision-making.
Jinke Property Group Co., Ltd. is a prominent real estate development company based in Chongqing, China, established in 1994. The company focuses on developing residential, industrial, and commercial properties while also providing property management services for various types of buildings, including residential complexes, commercial centers, office structures, and hotels. In addition to its core real estate activities, Jinke is involved in generating wind power and operating hotels. The company offers a range of services such as asset management, industrial investment, and wealth management, along with specialized services in landscape design and architectural decoration. It aims to integrate eco-friendly practices into its projects, emphasizing the development of green residential areas and eco-cities. Jinke has cultivated a strong organizational culture that contributes to its ongoing growth and operational effectiveness.
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.
Zeekr is a rapidly growing company focused on developing and manufacturing premium battery electric vehicles (BEVs). The company specializes in various aspects of automotive technology, including BEV architecture, hardware, and software innovations. Zeekr aims to lead the electrification and intelligentization of the automobile industry by offering next-generation electric vehicles and technology-driven solutions. In addition to vehicle production, Zeekr is engaged in the commercialization and sales of electric vehicles and batteries, as well as providing research and development services related to automotive technologies.
Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.
ArriVent Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for cancer. The company aims to address unmet medical needs by leveraging its team's extensive experience in drug development. ArriVent is advancing its lead candidate, furmonertinib, along with a pipeline of novel therapeutics, including next-generation antibody-drug conjugates. The company's initial emphasis is on solid tumors, reflecting its commitment to improving outcomes for cancer patients through differentiated medicines.
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.
Klook Travel Technology Limited, founded in 2014 and headquartered in Sheung Wan, Hong Kong, is a leading online platform for booking travel activities and services. The company collaborates directly with operators to provide a diverse range of offerings, including popular attractions, tours, local transportation, food experiences, and adventure activities across over 300 destinations. Klook’s innovative technology allows travelers to conveniently book and redeem services using QR code-enabled e-vouchers through its website and mobile app. Recognized for its user-friendly interface, the platform has received accolades from both Google Play and the Apple App Store. With a team that has grown to over 1,000 members, Klook aims to empower travelers by facilitating memorable experiences and adventures worldwide.
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.
D3 Bio Inc. is a biotechnology company founded in 2020 and based in China. It specializes in the development and registration of innovative medicines, primarily focusing on oncology and immunology. The company adopts a unique approach to medicine development by first identifying significant unmet patient and market needs, particularly in areas where current treatments are inadequate. This understanding informs their research and guides the selection of appropriate scientific and technological methods to define their drug development strategy. Through this differentiated approach, D3 Bio aims to address critical health challenges and improve clinical outcomes for patients.
Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.
Perfect Diary is an e-commerce-based cosmetic brand. The company is committed to exploring the trends in international cosmetics and the frontiers of fashion to provide easy-to-use cosmetics products for young Asian women.Perfect Diary is professional in branding and online traffic management. By launching co-branded cosmetic products with KOLs, idols and even some famous organizations like the British Museum
Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.
Pinduoduo operates an e-commerce platform in China, allowing users to engage in group buying deals primarily through Tencent's WeChat app. Founded in 2015 and headquartered in Shanghai, Pinduoduo offers a diverse range of products including apparel, electronics, household goods, and food items. The platform aims to facilitate access to the digital economy for local communities and small businesses, enhancing productivity and creating new opportunities. Pinduoduo has developed a robust network of sourcing, logistics, and fulfillment capabilities to support its operations and improve customer experience.
Beijing Kuaishou Technology Ltd. develops Kuaishou, an online video and photo sharing application launched in 2011. As one of the leading short video social platforms globally, Kuaishou has over 200 million daily active users and features 15 million user-generated content pieces uploaded daily. The platform aims to enhance individual happiness through the use of big data and artificial intelligence and is designed to showcase the diverse and often overlooked communities of China. Kuaishou enables users to share short videos, photos, and livestreams, fostering connections among people from various backgrounds. This approach allows ordinary citizens to engage with a global audience, offering a glimpse into their lives. The international counterpart, Kwai, mirrors Kuaishou's features while incorporating localized functions for users outside of China. With an extensive archive of 10 billion original short videos and 350 million daily likes, Kuaishou continues its mission to document human experiences and empower individuals worldwide.
Chengjia Apartment is a rental start-up based in Shanghai, China, that offers a variety of accommodation options including apartments, hotels, and homestays. Founded in 2015, the company provides flexible rental terms ranging from weekly to long-term stays, catering to diverse customer needs. Chengjia Apartment focuses on creating a high-quality living environment, combining the comforts of home with hotel-style services to ensure a warm and comfortable experience for its guests. The business has expanded significantly, managing nearly 100 properties across major cities in China and offering over 10,000 houses and related services. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital, reflecting a strong partnership in the hospitality sector.
Waterdrop is an insurance platform that plans to solve the problem of high medical fees faced by most patients, especially those with a critical illness. Shuidihuzhu offers three products: mutual insurance, crowdfunding and commercial insurance. All their services are conducted through the platform’s official WeChat account, where users could post crowdfunding campaigns, buy insurances, or claim indemnities according to their policies.
Yimidida is an online logistics network platform that provides crowd-sourced delivery services. Yimidida's logistics platform helps deliver products to villages in China and offers payment collection, transport insurance, return receipts, delivery tracking, improving dispatch, and truck deployment efficiency. It allows customers to receive their orders quickly, no matter what their location. Yimidida was founded in 2015 and is headquartered in Shanghai, China.
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.
NetEase Cloud Music, established in 2013 and based in Hangzhou, China, specializes in online music streaming services through its mobile application. The platform enables users to access a wide variety of music and offers additional features, such as music discovery and social networking capabilities. As a subsidiary of NetEase, Inc., NetEase Cloud Music has grown to become a significant player in the Chinese music streaming market, catering to the evolving preferences of its audience while developing applications for smartphones to enhance user experience.
Lianlian Yintong Electronic Payment Co., Ltd, commonly known as Lianlian Pay, is a prominent third-party payment service provider in China, established in 2003. Operating under its parent company, Lianlian Number, it ranks as the fourth largest non-bank payment processor in the country, with a registered capital of RMB325 million. Lianlian Pay specializes in mobile payment, clearing, and value-added services, having secured over 60 payment licenses across various regions. The company supports cross-border payments for approximately 100 sites on nearly 50 e-commerce platforms and extends its services to over 100 countries. It has been recognized as a key partner in the China (Hangzhou) Cross-border E-commerce Comprehensive Pilot Area since 2015. Lianlian's client base primarily includes small to midsized merchants and enterprises, with significant revenue generated from its global payment segment, alongside domestic payment and value-added services.
Klook Travel Technology Limited, founded in 2014 and headquartered in Sheung Wan, Hong Kong, is a leading online platform for booking travel activities and services. The company collaborates directly with operators to provide a diverse range of offerings, including popular attractions, tours, local transportation, food experiences, and adventure activities across over 300 destinations. Klook’s innovative technology allows travelers to conveniently book and redeem services using QR code-enabled e-vouchers through its website and mobile app. Recognized for its user-friendly interface, the platform has received accolades from both Google Play and the Apple App Store. With a team that has grown to over 1,000 members, Klook aims to empower travelers by facilitating memorable experiences and adventures worldwide.
Curon Biopharma is focused on developing drugs for immuno-oncology therapies. The company offers a range of innovative cancer immunotherapeutic agents aimed at overcoming the limitations of existing cancer treatment approaches. By providing advanced immunotherapies, Curon Biopharma enables physicians to enhance treatment options for their patients battling cancer.
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.
Trax Technology Solutions Pte Ltd. specializes in developing image recognition technology that provides real-time actionable insights for the retail sector. Founded in 2010 and headquartered in Singapore, Trax offers in-store execution solutions to major manufacturers and channel partners both locally and internationally. Its platform enables quick analysis of retail shelf images, allowing sales representatives to access critical information on product availability, planogram compliance, and pricing directly on their mobile devices. This technology enhances operational efficiency by helping companies identify performance gaps and revenue opportunities. Trax has established itself as a leader in computer vision solutions for consumer packaged goods and retailers, collaborating with notable global brands. The company also partners with innovators in IoT technologies to further enhance its capabilities in capturing retail realities.
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
China Chengxin Credit Co., Ltd. is a credit rating agency based in Beijing, China, with additional offices in Wuhan and Shanghai. Established in 2005, the company offers a variety of services related to credit information. For individuals, it provides personal credit services, including credit reports, credit scores, credit monitoring, anti-fraud measures, and tailored solutions. For businesses, it offers corporate credit services such as credit reports, e-commerce certifications, and pre-loan surveys for microfinance. Additionally, China Chengxin Credit is involved in social credit construction, helping regional governments and industries develop comprehensive credit systems. The company also engages in market research consulting, providing industry reports and management consulting services.
CStone Pharmaceuticals is a clinical-stage biotechnology company headquartered in Shanghai, China, dedicated to the development and commercialization of innovative immuno-oncology and molecularly targeted drugs aimed at addressing unmet medical needs in cancer treatment. Founded in 2015, the company has a diverse product pipeline that includes late-stage clinical candidates such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, targeting programmed death receptor. Other notable products include ivosidenib, avapritinib, and Pralsetinib, which are designed for various types of cancer, including gastrointestinal stromal tumors and medullary thyroid cancer. CStone has established strategic partnerships and collaborations, including agreements with Numab Therapeutics AG and Bayer HealthCare LLC, to enhance its research and development efforts. The company aims to provide effective therapeutic options tailored to the needs of cancer patients both in China and globally.
Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on developing treatments for severe inflammation and autoimmune diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, aimed at treating conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. The company is also advancing additional candidates, including VIB4920 for kidney transplantation rejection and Sjögren’s syndrome, as well as VIB7734 for cutaneous lupus erythematosus. Viela Bio has formed a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, the company is dedicated to addressing unmet medical needs in the field of autoimmune disorders.
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.
iQIYI, Inc. is a leading online entertainment provider in China, offering a diverse range of services including internet video, online games, live broadcasting, online literature, animations, and e-commerce. The platform features a vast library of licensed and self-produced video content, catering to the preferences of its users. Additionally, iQIYI provides membership options, content distribution, and online advertising services. The company operates various subsidiaries, including iQIYI Mall, which focuses on entertainment-related merchandise, and iQIYI Show, a live broadcasting service that connects users with popular hosts and celebrities. iQIYI Paopao serves as an entertainment-based social media platform, while the company also engages in talent agency and intellectual property licensing. Founded in 2009 and headquartered in Beijing, iQIYI was formerly known as Qiyi.com and rebranded in 2011. The company is a subsidiary of Baidu Holdings Limited and continues to compete with other major platforms in the industry.
CStone Pharmaceuticals is a clinical-stage biotechnology company headquartered in Shanghai, China, dedicated to the development and commercialization of innovative immuno-oncology and molecularly targeted drugs aimed at addressing unmet medical needs in cancer treatment. Founded in 2015, the company has a diverse product pipeline that includes late-stage clinical candidates such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, targeting programmed death receptor. Other notable products include ivosidenib, avapritinib, and Pralsetinib, which are designed for various types of cancer, including gastrointestinal stromal tumors and medullary thyroid cancer. CStone has established strategic partnerships and collaborations, including agreements with Numab Therapeutics AG and Bayer HealthCare LLC, to enhance its research and development efforts. The company aims to provide effective therapeutic options tailored to the needs of cancer patients both in China and globally.
COFCO is the largest supplier of diversified products and services in the agricultural products and food industry in China. It is devoted to utilizing renewable natural resources to provide healthy and nutritious food, high quality lifestyle and services, as well as contributing to improve people’s living standards, social prosperity and stability. COFCO plays a pivotal role as a bridge in the markets of edible oils and foodstuff between China and the world, and serves as the main importing and exporting channel for bulk agricultural products such as wheat, corn, rice and sugar. As an investment holding company specialized in trade and processing of oil and foodstuff as well as other businesses, COFCO continuously strives to upgrade its oil and foodstuff chains, which include those of oils and oilseeds, corn, wheat, rice, wine, tomatoes, dairy products, meat, barley, tea, chocolate and various other products. In light of China's economic growth, return on shareholders’ value and available business resources, COFCO is also involved in the development of real estate, hotels, non-grain bio-energy, packaging, finance and other industries.
LY.com allows users to search for places of interest at the local and city levels. LY.com pinpoints the right spots within a few clicks. Every place of interest comes with user reviews. If users are satisfied with the reviews, they can purchase tickets directly on the site. The company's goal is to become the leading service provider of leisure travel, making it easier for customers to enjoy travelling.
Founded in May 2010, Berry Genomics is the leading genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.
Alibaba Group is a leading global online and mobile commerce company based in Hangzhou, China, founded in 1999. The company operates a diverse range of platforms, including Taobao, a consumer-to-consumer marketplace, and Tmall, a business-to-consumer platform. Alibaba also manages Alibaba.com and 1688.com for wholesale transactions, along with AliExpress for international retail. Its services extend beyond e-commerce to cloud computing, digital media and entertainment, and local consumer services. Key assets include Cainiao, a logistics network, and Ele.me, a local delivery service. Additionally, Alibaba offers various marketing services, payment solutions, and operates content platforms such as Youku and Alibaba Pictures. As the world's largest online commerce entity by gross merchandise volume, Alibaba plays a crucial role in connecting consumers and businesses, facilitating transactions, and enhancing operational efficiencies through cutting-edge technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.